Epidemiology of Rheumatoid Arthritis: Rheumatoid Arthritis and Mortality
- 20 July 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Rheumatology Reports
- Vol. 12 (5), 379-385
- https://doi.org/10.1007/s11926-010-0117-y
Abstract
Increased mortality in rheumatoid arthritis (RA) is widely recognized but not fully explained. Despite substantial improvements in management and growing knowledge of the determinants of increased mortality, evidence for reduction in mortality in RA has lagged behind. Indeed, most studies report no apparent reduction in mortality in RA. However, emerging evidence from some recent RA inception cohorts suggests no increased mortality, including cardiovascular mortality, but this awaits further confirmation. Although it is possible that recent advances in RA treatment may manifest in improvement of survival in the near future, other factors, including undertreated or unrecognized low-grade inflammation, comorbidities, and immunogenetic factors, may contribute to the excess mortality in RA and impede its improvement. In this review, we summarize the current knowledge of the rates and determinants of mortality in RA, identify and discuss potential explanations for excess mortality, and outline promising research avenues for targeting mortality in RA.Keywords
This publication has 52 references indexed in Scilit:
- Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis?Arthritis & Rheumatism, 2010
- Telomerase insufficiency in rheumatoid arthritisProceedings of the National Academy of Sciences of the United States of America, 2009
- Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseasesAnnals Of The Rheumatic Diseases, 2009
- The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general populationArthritis & Rheumatism, 2008
- Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: A nested, case–control studyArthritis Care & Research, 2008
- Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groupsArthritis Care & Research, 2008
- High ten‐year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population‐based cohort studyArthritis & Rheumatism, 2008
- Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patientsAnnals Of The Rheumatic Diseases, 2008
- Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritisArthritis & Rheumatism, 2008
- Association of the HLA–DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritisArthritis & Rheumatism, 2008